Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C versus N-acetylcysteine in cardioplegic solution during on-pump CABG
IRCT20250112064360N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ascorbic acid and acetylcysteine in coronary arteriosclerosis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: cardiac ejection fraction, length of stay in ICU and 2 more. Started Feb 2025; status: completed.
02
Drugs
ascorbic acidacetylcysteine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20250112064360N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250112064360N1.